...

Why Solomon Islands Depends on Indian API Exporters: And How to Enter This Market

Introduction: The Critical Link in Solomon Islands’ Healthcare

The Import Reality

What would it be for a healthcare business to have a nation where 98% of all medicines are imported?

It is the case with the Solomon Islands, which is a small group of islands in the Pacific Ocean with a population of 838,000 people spread across over 900 islands.

The small and fragmented geographic nature of the country means that it cannot produce medicine locally and therefore relies on other countries.

Thus, on the road to becoming a trusted API supplier, there is a significant opportunity for Indian manufacturers to meet the needs of the Solomon Islands procurement teams.

solomon islands depends on indian api exporters

Every year, India shares USD 2.45 million in its pharmaceutical products with the Solomon Islands, and this number is increasing at a CAGR of 8.3% each year.

The growth of pharmaceutical export Solomon Islands India is justified by actual data, the demand for the management of diseases, and the structurally imbalanced position that India is likely to fill.

This blog covers the details of the diseases, demands, the laws, the shipping process, and the specific steps involved in starting the export process.

The India Connection

The Solomon Islands buys almost all of its medicines from other countries.

It will continue to be the case as the islands do not have the facilities and capability to produce medicines locally.

So who supplies them? India known as the “Pharmacy of the World” is the obvious choice. Every API supplier Solomon Islands collaborates with sees the value in India because:

  • India supplies medicines to over 200 countries.

  • India contributes to 20% of the total API in the world.

  • Indian medicines are 30-40% cheaper than medicines from Europe and the USA.

  • India has 500+ WHO-GMP approved plants, the most outside of Europe.

  • India’s total pharmacy export for FY2024 is USD 27.9 billion.

Pharmaceutical export Solomon Islands has also been made more reliable and easier because of the Forum for India-Pacific Islands Cooperation (FIPIC).

It also strengthens the partnership between India and 14 Pacific nations, including the Solomon Islands.

Healthcare and Disease Burden in Solomon Islands

To export the medicines, it is fundamental to identify the diseases that spread in Solomon Islands. The nation has a “double burden” of both infectious diseases and lifestyle diseases.

The Double Burden Infections + NCDs

  • Malaria: widespread, particularly in outer islands

  • Tuberculosis (TB): The Global Fund has committed USD 8 million (2024-2026) specifically for TB and malaria

  • Common infections: throat, chest, and stomach infections are treated with antibiotics from the National Medical Store all year round

healthcare and disease burden in solomon islands

Lifestyle Diseases / NCDs (Rising Diseases)

  • Diabetes, High Blood Pressure, Heart Disease, High Cholesterol

  • NCDs now account for 75%+ of all deaths in the Pacific Island countries and this percentage is increasing each year

Funding Landscape – Who Pays for the Medicines?

Funding SourceAmountWhat It Pays For
Global Fund (2024- 26)USD 8 millionAnti-TB and anti-malaria medicines
World BankGrantsGeneral medicine supply
ADB PacificGrantsHealth infrastructure + medicines
Government (MoH)Annual budgetNational Medical Store annual tender

Medicine procurement here is funded by several international donors, making Solomon Islands a low payment-risk market for any API supplier Solomon Islands is trying to enter.

Why Local Manufacturing is Missing and Why That’s India’s opportunity

Why can’t the Solomon Islands manufacture its own medicines? For the following basic reasons:

  • Lack of trained humans: There are no graduate chemical engineering or pharmaceutical pipeline programs

  • Inadequate Facilities: No functional electricity and no cold chain on the outer islands.

  • No raw material and technological support available

  • Lack of investors within the country to establish manufacturing

It is why the API supplier Solomon Islands gap India will fill because of the PLI scheme, where 6,940 crore will be used to stabilize supply for the Pacific Islands.

A guaranteed pharmaceutical export Solomon Islands India for the APIs because of the scheme, which produces 53 critical APIs by 2026.

Why Solomon Islands Cannot Manufacture Locally

CriteriaIndiaChinaEurope / USA
WHO-GMP Pacific certified plants500+PartialYes, but fewer
Zone IVb stability dataWidely availableLimitedRarely provided
PriceVery competitiveCompetitiveExpensive
FIPIC Pacific relationshipOfficialNoneNone
Supply stabilityPLI-backedVariableStable but costly
Regulatory trustHighModerateHigh

With the PLI-backed supply stability, the combination of WHO-GMP Pacific compliance, and Zone IVb stability dataavailability India ranks above the rest as the supplier of choice for the pharmaceutical export Solomon Islands India.

High-Demand API Categories in Solomon Islands

Below is a precise description of what the National Medical Store and donor- funded programs actively procure.

high demand api categories in solomon islands

Each API supplier Solomon Islands works with has to align its portfolio to this list:

Anti-Malaria APIs

Huge volume demand for Artemether, Lumefantrine, and Artesunate (funded by the Global Fund).

Anti-TB APIs

Rifampicin, Isoniazid, Pyrazinamide, and Ethambutol (are part of the government’s national DOTS program, so they have annual procurement by the government),

Antibiotic APIs

There is a constant demand for Amoxicillin, Azithromycin, Ciprofloxacin, and Metronidazole via the National Medical Store.

Fastest Growing Segment of NCD APIs

These include:

  • Metformin HCl and Glibenclamide (for diabetes).

  • Enalapril, Amlodipine, Losartan, and Atenolol (for blood pressure).

  • Atorvastatin and Simvastatin (for cholesterol).

  • Aspirin (for heart disease).

Zone IVb Stability Data: Non-Negotiable

The APIs that are being exported to the Solomon Islands must include Zone IVb stability data.

In simple terms, the Zone IVb stability data provides the evidence that the API was tested to 40 degrees Celsius and 75% of relative humidity for a period of a minimum of six months.

During this period, there were no changes to the effectiveness of the API.

The Ministry of Health will refuse any APIs that do not have Zone IVb stability data, irrespective of price or brand.

All sea freight must also use humidity-barrier foil pouches or HDPE containers with desiccants. Every API supplier ships has to comply with this mandatory packaging.

 Procurement Channels: How Solomon Islands Buys APIs

National Medical Store (NMS) Primary Channel

Procurement channels How Solomon Islands Buys APIs

NMS Honiara is the main procurement center for pharmacies and hospitals for the entire country of Solomon Islands. The process is as follows:

  • Annual tender runs in Q1 or Q2 each year

  • Suppliers must get pre-qualified with NMS Honiara before they can participate

  • First Technical Evaluation: WHO-GMP certification for the Pacific + Drug Master file + Zone IVb stability data

  • Then they will do a price comparison on all qualified suppliers

For any new suppliers of API, NMS Honiara is the suggested first point of contact.

Multilateral / Donor-Funded Procurement

  • The Global Fund provides a USD 8M grant that goes to purchasing anti- TB and anti-malaria APIs, and the suppliers are pre-qualified and, therefore, selected.

  • UNICEF also buys and distributes APIs for children, but the suppliers must be pre-qualified by WHO-GMP in the Pacific.

  • In order to gain access to these funds, they must be registered as a supplier on the WHO prequalification list and the GFATM (Global Fund ATM) approved supplier list.

Pooled Procurement: Melanesian Spearhead Group (MSG)

The Melanesian Spearhead Group is a collaboration of Papua New Guinea (PNG), Solomon Islands, Vanuatu, and Fiji, and together they have a population of over 10 million, which leads to pooled procurement of medicines.

This results in 20-40% less prices when compared to tenders from individual countries (WHO Report).

For the pharmaceutical export Solomon Islands India, the Melanesian Spearhead Group route provides much larger volumes and longer contract durations.

Tenders can be submitted to the pooled tender coordinator of the Melanesian Spearhead Group located in Port Vila or Honiara.

Logistics: The Singapore Route & Cold Chain

A Direct India to Honiara shipment takes 35-45 days and is only viable for consolidated shipments of 500+ kg. The only Main entry port is Point Cruz Wharf, Honiara.

If there are disruptive activities at the Red Sea on your route (Cape of Good Hope diversion), add 10-15 days.

Packaging and Cold Chain Rules

All shipments must include moisture barrier foil pouches OR HDPE containers with desiccants.

All shipments must include temperature data loggers as the Ministry of Health requires full temperature documentation.

Packaging must comply with Zone IVb stability data throughout the duration of the shipment.

For temperature-sensitive APIs: reefer containers check for availability on the Singapore-Honiara route before booking.

Documents for Customs Clearance

  • Certificate of Analysis (CoA): 1 per batch.

  • Certificate of Origin (CoO): India.

  • Copy of the WHO-GMP Pacific Certificate.

  • Zone IVb stability data report.

The customs of the Solomon Islands accept e-certificates to expedite the clearance process.

Key Challenges & How to Mitigate Them

Each API supplier collaborates with will have some genuine issues.

The obstacles and how to approach them.

ObstacleRealitySolution
Island Population and Small Order VolumesExporters determine minimum order quantities (MOQs), and customers buy at least that amountImplement pooled procurement through the Melanesian Spearhead Group and offer 5 to 50 kg sample batch purchases
High Freight CostsShipping costs are higher because of isolated locationsUse Singapore as a hub for cost-sensitive consolidation, along with FOB and batch shipping to reduce costs
Regulatory DelaysNMS Honiara / MoH registration takes 6 to 14 months depending on APIsRegister with Fiji first and reference it to get faster approval in the Solomon Islands
Currency and Payment RisksThe Solomon Islands Dollar (SBD) and foreign exchange controls are limitedUse a Letter of Credit through Bank of the South Pacific or ANZ for secure transactions
Regulatory Delays and FragmentationThere is no unified Pacific FDA, so islands have different regulationsPrioritize WHO-GMP prequalification, as most Pacific islands accept these standards
Cold Chain and StabilityAPIs that are unstable may degrade in tropical environments during transitProvide sealed HDPE/foil packaging and temperature data loggers with shipments
CompetitorsCompetitors may compromise on quality and complianceCompete using flexible MOQs, WHO-GMP trust, Zone IVb stability data, and English DMFs

Implications for Exporters

The common pitfall exporters to these islands fall into is seeing the Solomon Islands as a typical Southeast Asian Export Market, which it is not. Lengthy regulatory processes, small order sizes, and high freight costs are pervasive in unprepared exporters.

The answer is obvious: prepare to bid:

Before contacting any buyer, have your Zone IVb stability data ready.

To minimize the Solomon Islands registration regulatory timeline, register in Fiji first

Refer to the NMS Honiara tender as your first order, then use that reference to access the Melanesian Spearhead Group pooled volumes.

To keep freight costs manageable, always use Singapore consolidation for your shipments.

Letters of Credit are recommended over account opening terms with first- time buyers in the Pacific.

Indian exporters who foresee such issues and incorporate mechanisms to address them in their market entry strategy will secure contracts.

Those who do not will waste time, resources, and prospects, which will be exploited by rivals who are more prepared.

Market Entry Roadmap – Step-by-Step Market Entry Guide

market entry roadmap solomon islands

Route A: NMS Honiara Tender (Recommended First Step)

  • Step 1: Get a valid WHO-GMP Pacific certificate: this is your most important qualification document

  • Step 2: Zone IVb stability data dossier: 40° C / 75% RH with 6+ months of testing. This single document most differentiates you from your competition.

  • Step 3: Submitting the Drug Master File (DMF) to the Solomon Islands MoH will require a wait time of 3-6 months for review.

  • Step 4: For the NMS Honiara pre-qualification, submit the company profile, WHO-GMP Pacific certification, a list of products, and Zone IVb stability data.

  • Step 5: Participate in the NMS Honiara Q1or Q2 annual tender: If you are technically compliant, you will be shortlisted for the award, which goes to the lowest priced bidder.

Route B: Global Fund / UNICEF Channel

Apply as early as possible for the WHO-GMP Pacific Prequalification (12-18 months) to be able to list on the GFATM-approved suppliers’ list.

Once listed, you will be eligible for the Solomon Islands grant of USD 8M, as well as the same amount in grants for all 14 FIPIC Pacific countries.

Route C: Melanesian Spearhead Group Route

Register in Fiji, the simplest Pacific gateway to Indian exporters.

Use Fiji’s approval for mutual recognition in the Solomon Islands.

Join the Melanesian Spearhead Group pooled tender covering PNG, the Solomon Islands, Vanuatu, and Fiji.

It offers higher volumes, longer contract durations, and much less price competition than any single island tender

Future Outlook: What is Anticipated by 2030

The 2030 Vision

A total of USD 500M from the World Bank and ADB has been assigned to the Pacific health investments from 2024-2028.

The NCD epidemic will drive 10 years of sustained demand for Metformin, Atorvastatin, Amlodipine, guaranteeing continuous procurement for every API supplier of Solomon Islands.

India’s FIPIC III commitments will bring priority pharmaceutical exports from India to the Solomon Islands above all 14 Pacific Island countries.

Indian exporters who meet the NMS Honiara pre-qualification and WHO- GMP Pacific certifications will be the first to win the Pacific tenders for 2027- 2030.

As procurement budgets of the Melanesian Spearhead Group increase due to larger donor grants for member countries, this pattern is likely to continue.

“For Indian API exporters, the Solomon Islands is more than a small island market; it is an entry point to a USD 500M+ healthcare investment pipeline in the Pacific.

Those exporters who meet the Zone IVb stability data along with WHO-GMP Pacific certification will have a secure supply relationship for the entirety of the decade.”

Key Takeaways

The Solomon Islands is an almost entirely import-dependent country, which means that there will always be a consistent demand for a reliable API supplier.

Zone IVb stability data is not discretionary; it is a single document that will set you apart from the rest.

Begin with NMS Honiara and then expand to the Melanesian Spearhead Group and donor channels.

WHO-GMP Pacific certification opens all procurement pathways.

In all Pacific markets, quality and reliability will always prevail.

Frequently Asked Questions

Q1: How do I register my API in Solomon Islands?

Approach the Solomon Islands MoH. File a Drug Master File (DMF) alongside your WHO-GMP Pacific certificate, Zone IVb stability data, and Certificate of Analysis.

Then, pre-qualify with NMS Honiara to obtain the right to participate in annual tenders. It is the typical starting point for any API provider Solomon Islands is interested in onboarding.

Q2: What is Zone IVb stability data, and why is it required?

Zone IVb stability data demonstrates that the API has undergone testing at 40° Celsius with 75% humidity for a minimum of 6 months and has proven to be fully efficacious.

In the absence of this data, NMS Honiara will not consider your product, and this is non-negotiable.

Q3: Which APIs are most in demand?

Anti-infectives: Artemether, Lumefantrine (antimalarial), Rifampicin, Isoniazid (anti-TB), Amoxicillin, and Ciprofloxacin (antibacterial).

In the NCD segment, Metformin HCl, Amlodipine, and Atorvastatin are the highest growth drivers for pharmaceutical export Solomon Islands India manufacturers.

Q4: How long does it take to ship?

Through the Singapore hub, it takes 20-30 days. A direct route takes 35-45 days and is applicable to large shipments only.

Additionally, Red Sea disruptions can cause delays of 10-15 days. Lastly, all packaging must be in compliance with Zone IVb stability data requirements during the entirety of the journey.

Q5: What is the Melanesian Spearhead Group?

The Melanesian Spearhead Group is a trade bloc in the Pacific, comprising Papua New Guinea, Solomon Islands, Vanuatu, and Fiji, and has a population of over 10 million.

Pooled procurement yields 20-40% savings in pricing. It is the most optimal long-term volumetric opportunity for any API supplier in Solomon Islands that meets the qualifications for Solomon Islands.

Q6: What MOQ should I expect?

Individual government tenders range from 50-200kg per API per year. Pooled orders from the Melanesian Spearhead Group are much larger.

Begin with NMS Honiara to establish your supply history, then expand to the Melanesian Spearhead Group.

Q7: Does the Global Fund apply to Solomon Islands?

Yes, it is. There is an active grant of 8 million dollars for the year 2024 through 2026. There is a requirement for the WHO-GMP Pacific certification and the status of a GFATM-approved supplier.

It is the best way to scale pharmaceutical export Solomon Islands India to India beyond the standard government tenders.

Q8: What payment terms do buyers use?

Government tenders use Letters of Credit (LC) or purchase orders that are confirmed.

Donor channels follow payments that are split per the multilateral payment guidelines. Always check the payment terms during the pre-qualification, not after winning the tender.

About the Author

Nilesh Mendpara MD of ACTIZA PHARMA Profile Image
Nilesh Mendpara

Nilesh Mendpara is the Managing Director of Actiza Pharmaceutical PVT. LTD., based in Surat, Gujarat, India. With over 10 years of experience in the pharmaceutical industry, Nilesh is passionate about spreading pharmaceutical knowledge and staying ahead of industry trends. He holds a Master of Pharmacy (Distinction) and a Bachelor's in Pharmacy from Rajiv Gandhi University of Health Sciences. Under his leadership, Actiza Pharmaceutical aims to be the most trusted partner for pharmaceutical exports worldwide, ensuring the highest standards of quality and safety. Connect with Nilesh to explore opportunities in advancing global healthcare.

[Read more]
Request A Call Back

We are a 100% export-oriented company and do not engage in domestic sales within India.